GlassScriptPhysician profile
Caetlyn Best
NPI 1952941569
$4,812.62
in general payments reported to CMS, 2019-2025
12 companies · $826 in 2025
The $826 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $387 · 2022: $697 · 2023: $1,073 · 2024: $1,829 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,945 · Travel and Lodging: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,945.03 |
| Travel and Lodging | $783.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,530.74 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $895.92 | 2024-2025 | |
| Boston Scientific Corporation | $543.40 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Zimvie INC. | $250.94 | 2022-2024 | |
| Smith+Nephew, INC. | $183.68 | 2021-2024 | Grafix Pl, Stravix Pl, Stravix |
| Stryker Corporation | $145.31 | 2022-2023 | Spinemap |
| Zimmer Biomet Holdings, INC. | $116.57 | 2021-2022 | |
| Biocomposites INC | $41.76 | 2025 | Stimulan |
| Cerapedics INC. | $37.94 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $25.50 | 2023 | Senza |
| Depuy Synthes Sales INC. | $22.94 | 2024 | X-Pac |
| Aesculap, INC. | $17.92 | 2023 | M.Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caetlyn Best listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.